GLI1 and glioblastoma: To evaluate the effect of the identified GANT61 analogs on cancer cell viability, we first assessed the expression of GLI1 and GLI2 in two human glioblastoma cell lines, U87MG and T98G, previously shown to be GANT61-sensitive and GLI1-dependent [71,72,73].